Addressing time-dependent CYP 3A4 inhibition observed in a novel series of substituted amino propanamide renin inhibitors, a case study.
Chen, Austin; Dubé, Daniel; Dubé, Laurence; Gagné, Sébastien; Gallant, Michel; Gaudreault, Mireille; Grimm, Erich; Houle, Robert; Lacombe, Patrick; Laliberté, Sébastien; Liu, Suzanna; MacDonald, Dwight; Mackay, Bruce; Martin, David; McKay, Dan; Powell, David; Lévesque, Jean-François.
Bioorg Med Chem Lett
; 20(17): 5074-9, 2010 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-20673718
Integrated in silico-in vitro strategy for addressing cytochrome P450 3A4 time-dependent inhibition.
Inhibitory effects of curcumenol on human liver cytochrome P450 enzymes.
Time- and NADPH-Dependent Inhibition on CYP3A by Gomisin A and the Pharmacokinetic Interactions between Gomisin A and Cyclophosphamide in Rats.
In vitro metabolism of glycyrrhetic acid by human cytochrome P450.
Mechanism-based inactivation of cytochrome P450 3A4 by lapatinib.
Studies of CDK 8/19 inhibitors: Discovery of novel and selective CDK8/19 dual inhibitors and elimination of their CYP3A4 time-dependent inhibition potential.
Benzoxazole and benzothiazole amides as novel pharmacokinetic enhancers of HIV protease inhibitors.
A systematic approach to evaluate herb-drug interaction mechanisms: investigation of milk thistle extracts and eight isolated constituents as CYP3A inhibitors.
Quercetin nanoparticles alter pharmacokinetics of bromocriptine, reflecting its enhanced inhibitory action on liver and intestinal CYP 3A enzymes in rats.
Characterization of ritonavir-mediated inactivation of cytochrome P450 3A4.